KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

May 22, 2025 at 21:01 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Media Contact

Naomi Goumillout

Agilent Technologies

+1.978.314.1862

naomi.goumillout@agilent.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

Lennar Q2 Earnings Call Highlights ↗

Today 13:03 EDT

Via MarketBeat

Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ↗

Today 12:35 EDT

Via MarketBeat

3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation ↗

Today 12:00 EDT

Via MarketBeat

The 127-Gigawatt Problem: Why AI Needs Its Own Power ↗

Today 11:25 EDT

Via MarketBeat

ERock IPO: A $1.3B Power Play Solution ↗

Today 10:50 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	236.91	-4.60 (-1.90%)
AAPL	291.07	-4.56 (-1.54%)
AMD	514.16	+25.71 (5.26%)
BAC	55.63	+0.48 (0.86%)
GOOG	360.14	+3.58 (1.00%)
META	570.50	+2.07 (0.36%)
MSFT	387.85	-2.49 (-0.64%)
NVDA	205.13	+0.26 (0.13%)
ORCL	182.63	-1.47 (-0.80%)
TSLA	399.03	-0.12 (-0.03%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.